Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma.

Authors :: Yutaka T
Ito S
Ohigashi H
Naohiro M
Shimono J
Souichi S
Teshima T
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (11), pp. 3216-8. Date of Electronic Publication: 2015 May 12.
Publication Year :: 2015

Subjects :: Antineoplastic Combined Chemotherapy Protocols adverse effects
Bendamustine Hydrochloride administration & dosage
Humans
Lymphocyte Count
Lymphopenia blood
Lymphopenia diagnosis
Maintenance Chemotherapy
Rituximab administration & dosage
Rituximab adverse effects
Antineoplastic Combined Chemotherapy Protocols therapeutic use
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Lymphoma complications
Lymphoma drug therapy
Lymphopenia etiology
Rituximab therapeutic use

Full Text Access

Tools